Table I. Disease specific survival analysis of the NKG2D ligands MIC, RAET1E, RAET1G, ULBP1, ULBP2 and ULBP3.
Data presented for each ligand expression case. Combinations of ligand expression are only presented in cases where statistical significance was found.
Variable | Mean DSS (months) |
Survival range (months) |
Log-rank p-value |
Cox regression p-value |
HR | Lower CI |
Upper CI |
---|---|---|---|---|---|---|---|
MICA expression |
|||||||
High | 68 | 62-74 | 0.035 | 0.04 | 0.76 | 0.59 | 0.99 |
Low | 56 | 47-65 | |||||
| |||||||
ULBP1 expression |
|||||||
High | 67 | 61-73 | 0.055 | 0.045 | 0.81 | 0.64 | 1.05 |
Low | 58 | 50-66 | |||||
| |||||||
ULBP2 expression |
|||||||
High | 60 | 54-66 | 0.466 | 0.39 | 1.13 | ||
Low | 67 | 60-74 | |||||
| |||||||
ULBP3 expression |
|||||||
High | 66 | 58-74 | 0.53 | 0.492 | 0.91 | ||
Low | 63 | 57-70 | |||||
| |||||||
RAET1E expression |
|||||||
High | 65 | 58-72 | 0.642 | 0.299 | 0.84 | ||
Low | 64 | 57-71 | |||||
| |||||||
RAET1G expression |
|||||||
High | 74 | 65-83 | 0.01 | 0.03 | 0.74 | 0.551 | 1 |
Low | 62 | 56-67 | |||||
| |||||||
MICA and ULBP1 |
|||||||
Both high | 67 | 60-73 | 0.018 | 0.006 | 0.83 | 0.7 | 0.97 |
Single high | 66 | 57-74 | |||||
Both low | 50 | 38-62 | |||||
| |||||||
MICA and RAET1E |
|||||||
Both high | 68 | 62-74 | 0.02 | 0.014 | 0.86 | 0.77 | 0.97 |
Single high | 61 | 51-72 | |||||
Both low | 44 | 30-59 | |||||
| |||||||
MICA and RAET1G |
|||||||
Both high | 77 | 68-87 | 0.003 | 0.005 | 0.84 | 0.74 | 0.95 |
Single high | 64 | 56-71 | |||||
Both low | 54 | 44-64 | |||||
| |||||||
ULBP1 and RAET1E |
|||||||
Both high | 68 | 59-72 | 0.041 | 0.039 | 0.81 | ||
Single high | 62 | 55-70 | |||||
Both low | 45 | 27-63 | |||||
| |||||||
ULBP1 and RAET1G |
|||||||
Both high | 73 | 63-84 | 0.027 | 0.032 | 0.83 | ||
Single high | 65 | 58-72 | |||||
Both low | 57 | 48-65 | |||||
| |||||||
RAET1E and RAET1G |
|||||||
Both high | 76 | 67-86 | 0.004 | 0.002 | 0.84 | 0.77 | 0.99 |
Single low/ Both low |
61 | 55-67 |